Cell Versus Chemokine Therapy Effects on Cell Mobilization to Chronically Dysfunctional Urinary Sphincters of Nonhuman Primates
Open Access
- 31 December 2018
- journal article
- research article
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 22 (4) , 260-267
Abstract
A major question remaining in approaches to tissue engineering and organ replacement is the role of native mobilized native cells in the regeneration process of damaged tissues and organs. The goal of this study was to compare the cell mobilizing effects of the chemokine CXCL12 and cell therapy on the urinary sphincter of nonhuman primates (NHP) with chronic intrinsic urinary sphincter dysfunction. Either autologous lenti-M-cherry labeled skeletal muscle precursor cells (skMPCs) or CXCL12 were injected directly into the sphincter complex of female NHPs with or without surgery-induced chronic urinary sphincter dysfunction (n=4/treatment condition). All monkeys had partial bone marrow transplantation with autologous lenti-green fluorescent protein (GFP) bone marrow cells prior to treatment. Labeled cells were identified, characterized and quantified using computer-assisted immunohistochemistry 6 months posttreatment. GFP-labeled bone marrow cells (BMCs) were identified in the bone marrow and both BMCs and skMPCs were found in the urinary sphincter at 6-month postinjection. BMCs and skMPCs were present in the striated muscle, smooth muscle, and lamina propria/urothelium of the sphincter tissue. Sphincter injury increased the sphincter content of BMCs when analyzed 6-month postinjection. CXCL12 treatment, but not skMPCs, increased the number of BMCs in all layers of the sphincter complex (P<0.05). CXCL12 only modestly (P=0.15) increased the number of skMPCs in the sphincter complex. This dual labeling methodology now provides us with the tools to measure the relative number of locally injected cells versus bone marrow transplanted cells. The results of this study suggest that CXCL12 promotes mobilization of cells to the sphincter, which may contribute more to sphincter regeneration than injected cells.Keywords
Funding Information
- National Institutes of Health (R01 DK 083688)
This publication has 13 references indexed in Scilit:
- New imaging probes to track cell fate: reporter genes in stem cell researchCellular and Molecular Life Sciences, 2017
- Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiencyStem Cell Research & Therapy, 2017
- Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter DeficiencyJournal of Urology, 2016
- Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiencyStem Cell Research & Therapy, 2016
- Strategies to Optimize Adult Stem Cell Therapy for Tissue RegenerationInternational Journal of Molecular Sciences, 2016
- Long-Term Structural and Functional Effects of Autologous Muscle Precursor Cell Therapy in a Nonhuman Primate Model of Urinary Sphincter DeficiencyJournal of Urology, 2013
- A Nonhuman Primate Model of Stable Urinary Sphincter DeficiencyJournal of Urology, 2013
- Vascular therapy for radiation cystitisNeurourology and Urodynamics, 2010
- The Effects of Ethanol Consumption on Vasculogenesis Potential in Nonhuman PrimatesAlcohol, Clinical and Experimental Research, 2007
- Magnetic Resonance Tracking of Transplanted Stem Cells in Rat Brain and Spinal CordNeurodegenerative Diseases, 2006